Skip to main content
Top
Published in: Journal of Cancer Education 4/2015

01-12-2015

The Development of a Communication Tool to Facilitate the Cancer Trial Recruitment Process and Increase Research Literacy among Underrepresented Populations

Authors: Samantha Torres, Erika E. de la Riva, Laura S. Tom, Marla L. Clayman, Chirisse Taylor, Xinqi Dong, Melissa A. Simon

Published in: Journal of Cancer Education | Issue 4/2015

Login to get access

Abstract

Despite increasing need to boost the recruitment of underrepresented populations into cancer trials and biobanking research, few tools exist for facilitating dialogue between researchers and potential research participants during the recruitment process. In this paper, we describe the initial processes of a user-centered design cycle to develop a standardized research communication tool prototype for enhancing research literacy among individuals from underrepresented populations considering enrollment in cancer research and biobanking studies. We present qualitative feedback and recommendations on the prototype’s design and content from potential end users: five clinical trial recruiters and ten potential research participants recruited from an academic medical center. Participants were given the prototype (a set of laminated cards) and were asked to provide feedback about the tool’s content, design elements, and word choices during semi-structured, in-person interviews. Results suggest that the prototype was well received by recruiters and patients alike. They favored the simplicity, lay language, and layout of the cards. They also noted areas for improvement, leading to card refinements that included the following: addressing additional topic areas, clarifying research processes, increasing the number of diverse images, and using alternative word choices. Our process for refining user interfaces and iterating content in early phases of design may inform future efforts to develop tools for use in clinical research or biobanking studies to increase research literacy.
Literature
1.
go back to reference Swanson GM, Bailar JC 3rd (2002) Selection and description of cancer clinical trials participants—science or happenstance? Cancer 95(5):950–9CrossRefPubMed Swanson GM, Bailar JC 3rd (2002) Selection and description of cancer clinical trials participants—science or happenstance? Cancer 95(5):950–9CrossRefPubMed
2.
go back to reference The Unequal Burden of Cancer (1999) An assessment of NIH research and programs for ethnic minorities and the medically underserved. In: Haynes MA and Smedley BD (eds) The National Academies Press The Unequal Burden of Cancer (1999) An assessment of NIH research and programs for ethnic minorities and the medically underserved. In: Haynes MA and Smedley BD (eds) The National Academies Press
3.
go back to reference Colon-Otero G et al (2008) Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 112(3):447–54CrossRefPubMed Colon-Otero G et al (2008) Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 112(3):447–54CrossRefPubMed
4.
go back to reference Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–42CrossRefPubMed Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–42CrossRefPubMed
5.
go back to reference Ford JG et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess (Summ) (122):1–11 Ford JG et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess (Summ) (122):1–11
6.
go back to reference Byrne MM et al (2013) Participation in cancer clinical trials: why are patients not participating? Med Decis Making Byrne MM et al (2013) Participation in cancer clinical trials: why are patients not participating? Med Decis Making
7.
go back to reference Rivers D et al (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRefPubMed Rivers D et al (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRefPubMed
8.
go back to reference Simon CM, Kodish ED (2005) Step into my zapatos, doc: understanding and reducing communication disparities in the multicultural informed consent setting. Perspect Biol Med 48(1 Suppl):S123–38CrossRefPubMed Simon CM, Kodish ED (2005) Step into my zapatos, doc: understanding and reducing communication disparities in the multicultural informed consent setting. Perspect Biol Med 48(1 Suppl):S123–38CrossRefPubMed
9.
go back to reference Paasche-Orlow MK, Taylor HA, Brancati FL (2003) Readability standards for informed-consent forms as compared with actual readability. N Engl J Med 348(8):721–6CrossRefPubMed Paasche-Orlow MK, Taylor HA, Brancati FL (2003) Readability standards for informed-consent forms as compared with actual readability. N Engl J Med 348(8):721–6CrossRefPubMed
10.
go back to reference Flory J, Emanuel E (2004) Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA 292(13):1593–601CrossRefPubMed Flory J, Emanuel E (2004) Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA 292(13):1593–601CrossRefPubMed
11.
go back to reference Cortes DE et al (2010) How to achieve informed consent for research from Spanish-speaking individuals with low literacy: a qualitative report. J Health Commun 15(Suppl 2):172–82CrossRefPubMed Cortes DE et al (2010) How to achieve informed consent for research from Spanish-speaking individuals with low literacy: a qualitative report. J Health Commun 15(Suppl 2):172–82CrossRefPubMed
12.
go back to reference Tamariz L et al (2012) Improving the informed consent process for research subjects with low literacy: a systematic review. J Gen Intern Med Tamariz L et al (2012) Improving the informed consent process for research subjects with low literacy: a systematic review. J Gen Intern Med
13.
go back to reference Falagas ME et al (2009) Informed consent: how much and what do patients understand? Am J Surg 198(3):420–35CrossRefPubMed Falagas ME et al (2009) Informed consent: how much and what do patients understand? Am J Surg 198(3):420–35CrossRefPubMed
14.
go back to reference Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9(5):485–93CrossRefPubMed Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9(5):485–93CrossRefPubMed
15.
go back to reference Jefford M et al (2011) Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem. Support Care Cancer 19(3):371–9CrossRefPubMed Jefford M et al (2011) Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem. Support Care Cancer 19(3):371–9CrossRefPubMed
16.
go back to reference Lorenzen B, Melby CE, Earles B (2008) Using principles of health literacy to enhance the informed consent process. AORN J 88(1):23–9CrossRefPubMed Lorenzen B, Melby CE, Earles B (2008) Using principles of health literacy to enhance the informed consent process. AORN J 88(1):23–9CrossRefPubMed
17.
go back to reference Breese PE et al (2007) Education level, primary language, and comprehension of the informed consent process. J Empir Res Hum Res Ethics 2(4):69–79CrossRefPubMed Breese PE et al (2007) Education level, primary language, and comprehension of the informed consent process. J Empir Res Hum Res Ethics 2(4):69–79CrossRefPubMed
18.
go back to reference Simon MA et al (2014) Improving diversity in cancer research trials: the story of the cancer disparities research network. J Cancer Educ Simon MA et al (2014) Improving diversity in cancer research trials: the story of the cancer disparities research network. J Cancer Educ
19.
go back to reference Abras C, Maloney-Krichmar D, Preeces J (2004) User-centered design. Encyclopedia of human-computer interaction. Sage Publications, Thousand Oaks Abras C, Maloney-Krichmar D, Preeces J (2004) User-centered design. Encyclopedia of human-computer interaction. Sage Publications, Thousand Oaks
21.
go back to reference Snyder C (2003) Paper prototyping: the fast and easy way to design and refine user interfaces. Morgan Kaufmann Publishers, San Francisco, CA Snyder C (2003) Paper prototyping: the fast and easy way to design and refine user interfaces. Morgan Kaufmann Publishers, San Francisco, CA
22.
go back to reference The Plain Language Action and Information Network (2011) Federal plain language guidelines (revision 1) The Plain Language Action and Information Network (2011) Federal plain language guidelines (revision 1)
23.
go back to reference Centers for Disease Control and Prevention (2013) CDC clear communication index: a tool for developing and assessing CDC public communication products (user guide): Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication Centers for Disease Control and Prevention (2013) CDC clear communication index: a tool for developing and assessing CDC public communication products (user guide): Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication
24.
go back to reference Glaser, B.G (1965) The constant comparative method of qualitative analysis social problems. p. 436–445 Glaser, B.G (1965) The constant comparative method of qualitative analysis social problems. p. 436–445
25.
Metadata
Title
The Development of a Communication Tool to Facilitate the Cancer Trial Recruitment Process and Increase Research Literacy among Underrepresented Populations
Authors
Samantha Torres
Erika E. de la Riva
Laura S. Tom
Marla L. Clayman
Chirisse Taylor
Xinqi Dong
Melissa A. Simon
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2015
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0818-z

Other articles of this Issue 4/2015

Journal of Cancer Education 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine